Like all growth stocks, medical device maker Medtronic (NYSE: MDT) had a difficult 2022, with its stock plunging 25%. However, 2023 appears to be off to a good start for the company. The stock is up 8%, compared to a 4.5% gain for the S&P 500.
On Feb. 21, the company reported its third-quarter fiscal 2023 results, with a positive outlook for the rest of the year. Let's dig into its quarterly results to determine if Medtronic is a good buy right now.
MDT EPS Diluted (Annual) data by YCharts
Source Fool.com